Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | — | — |
COVID-19; COVID-19; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 63-year-old patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 07Feb2025, outcome "unknown" and all described as "COVID-19". The clinical course was reported as follows: The patient had the Pfizer, the first Pfizer, then the patient had the booster, and then had another booster. The patient did not get the vaccine this year and actually got COVID 10 days ago. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.